Mindmaze expands global reach with four new partners

MindMaze Healthcare’s digital neurotherapeutics (DTx) solutions combine neuroscience with engaging, serious game-based medical software supported by tailored smart peripherals that target two distinct areas: neurorehabilitation (Rehab DTx) and neuro-restoration (Neuro DTx).

The Company's animated therapeutic 'games' aid patients suffering with neurological injuries and conditions such as stroke, traumatic brain injury, multiple sclerosis, or Parkinson's disease. They were created to be as highly engaging as video games while promoting the high dose, high intensity therapeutic movements that lead to restoration of function.

"MindMaze's evidence-based interventions are leading an international paradigm shift in delivering novel, evidence-based therapies to patients for improved outcomes," noted John Krakauer, M.A., M.D., Professor of Neurology at Johns Hopkins University School of Medicine, Director of the Center for the Study of Motor Learning and Brain Repair, and Chief Medical Advisor to MindMaze.  "Importantly, MindMaze digital neurotherapeutic products are used across the continuum of care, from the hospital to home, offering patients a hybrid therapy program delivered through sessions in person and remotely that result in reduced therapy delivery costs and greater patient management and monitoring."

New partners include:

• Alkoholi Medical: Founded in 1976 by Dr. Hamza Alkholi, Alkholi Medical has been at the forefront of bringing healthcare solutions closer to the people who need it the most in the Kingdom of Saudi Arabia. 
• Surgicorp has over twenty years of experience in medical biotechnology in Peru, Ecuador and Bolivia. 
• Swiss Rehabilitation: With leading rehabilitation centers in Vaud, Swiss Rehabilitation specializes in neurology services.
• Guttmann Barcelona is a clinic that is specially designed to offer the best diagnosis and most advanced treatments in functional motor, cognitive and behavioural problems

"MindMaze products have proved to be the best in the market, as validated by the leading US institutions in the field. Thanks to distributors and partners, we can reach more patients faster, so that people with neurological diseases all around the world can benefit first-hand from these proven engaging and immersive therapies, including from the comfort of their own home," said Jean-Marc Wismer, MindMaze's Chief Operating Officer. "The partnerships collectively expand MindMaze's international footprint, which should further solidify our leadership in brain health while contributing to our top line growth over the coming year and beyond."